Education And Debate
The PROGRESS trial three years later: time for a balanced report of effectiveness
BMJ 2004; 329 doi: https://doi.org/10.1136/bmj.329.7472.968 (Published 21 October 2004) Cite this as: BMJ 2004;329:968
Related articles
- Editor's Choice Published: 21 October 2004; BMJ 329 doi:10.1136/bmj.329.7472.0-g
- Commentary Published: 21 October 2004; BMJ 329 doi:10.1136/bmj.329.7472.970
- RESEARCH Published: 24 February 2006; BMJ doi:10.1136/bmj.38758.600116.AE
- Research Published: 16 March 2006; BMJ 332 doi:10.1136/bmj.38758.600116.AE
- Letter Published: 21 July 2005; BMJ 331 doi:10.1136/bmj.331.7510.235-b
- Letter Published: 13 January 2005; BMJ 330 doi:10.1136/bmj.330.7483.145
- Letter Published: 09 December 2004; BMJ 329 doi:10.1136/bmj.329.7479.1404-b
- Letter Published: 09 December 2004; BMJ 329 doi:10.1136/bmj.329.7479.1403-d
- Letter Published: 09 December 2004; BMJ 329 doi:10.1136/bmj.329.7479.1404
- Letter Published: 09 December 2004; BMJ 329 doi:10.1136/bmj.329.7479.1404-a
- Letter Published: 17 February 2005; BMJ 330 doi:10.1136/bmj.330.7488.421-b
See more
- Stroke: Take test for genetic variant to ensure clopidogrel works for prevention, says NICEBMJ May 19, 2023, 381 p1146; DOI: https://doi.org/10.1136/bmj.p1146
- David Oliver: What the plan for social care omittedBMJ September 10, 2021, 374 n2227; DOI: https://doi.org/10.1136/bmj.n2227
- Stroke: “striking reductions” are seen in number of people with symptoms seeking helpBMJ April 06, 2020, 369 m1406; DOI: https://doi.org/10.1136/bmj.m1406
- NICE recommends implantable monitor to identify atrial fibrillation after strokeBMJ January 14, 2020, 368 m133; DOI: https://doi.org/10.1136/bmj.m133
- Thrombectomy can be considered up to 24 hours after onset of stroke, says NICEBMJ November 23, 2018, 363 k4995; DOI: https://doi.org/10.1136/bmj.k4995
Cited by...
- Are Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Especially Useful for Cardiovascular Protection?
- Blockage of the Renin-Angiotensin System in the Secondary Prevention of Stroke: Beneficial Effects Beyond Blood Pressure Reduction?
- Applicability to primary care of national clinical guidelines on blood pressure lowering for people with stroke: cross sectional study
- Perindopril monotherapy and PROGRESS in Europe
- Trial protocols: time for more than tinkering
- Users' guide to detecting misleading claims in research: Misleading claims may be symptom of even more serious flaws
- The PROGRESS trial three years later: Clear and accurate interpretations of studies are needed
- The PROGRESS trial three years later: HOPE trial may shed some light
- The PROGRESS trial three years later: All aspects of secondary prevention after stroke need to be improved
- The PROGRESS trial three years later: Evangelism is understandable
- The PROGRESS trial three years later: time for more action, less distraction